Funded Startups in Eindhoven
Disclosed round sizes in Eindhoven skew heavily toward a single outlier: Axelera AI’s $250M round (2026-02-24) is far above the rest of the disclosed amoun…
Disclosed round sizes in Eindhoven skew heavily toward a single outlier: Axelera AI’s $250M round (2026-02-24) is far above the rest of the disclosed amounts, which range down to $200K (Belcapo, 2020-10-07). Most disclosed rounds cluster in the multi-million band, including several $40M–$100M closes (e.g., RIFT $97M on 2026-03-03; Salvia BioElectronics $60M on 2025-05-27; Microsure $40M on 2023-10-04), but nothing except Axelera AI reaches that $250M level.
The timing is also concentrated near the present: the 49 rows span 2020-10-07 (Belcapo, $200K) through 2026-06-22 (genexis, undisclosed). A dense late window shows multiple large filings in 2026 (e.g., Eyeo $47M on 2026-05-11; Onward $48M on 2026-04-16; RIFT $97M on 2026-03-03; Axelera AI $250M on 2026-02-24), while 6 of the 49 entries are explicitly “undisclosed” and 30 of the 49 are labeled “Series Unknown,” limiting stage-based clustering.
Most recent rounds
49 shownRelated listings
Frequently asked
Which single disclosed round stands out most in Eindhoven, and how does it compare to other disclosed amounts in the list?
Axelera AI’s $250M round on 2026-02-24 is an outlier; the next-largest disclosed amounts shown are in the tens of millions (for example, RIFT $97M on 2026-03-03 and Salvia BioElectronics $60M on 2025-05-27), while the smallest disclosed amount is $200K for Belcapo on 2020-10-07.
Do the most recent financings cluster in a narrow time window (e.g., within the last ~3–6 months of the listing)?
Yes. Multiple rounds land in early-to-mid 2026, including RIFT $97M (2026-03-03), Onward $48M (2026-04-16), Eyeo $47M (2026-05-11), and Axelera AI $250M (2026-02-24). This sits alongside 2026-06-08 (Touchwaves, undisclosed) and 2026-06-22 (genexis, undisclosed), keeping several entries near the current end of the timeline.
How much of the list is missing stage disclosure, and does that limit stage-based patterning?
Stage disclosure is incomplete: 30 of 49 entries are labeled “Series Unknown,” and 6 of 49 are “undisclosed” on the amount side (e.g., genexis on 2026-06-22 and Touchwaves on 2026-06-08). That means any stage concentration analysis is largely constrained to the remaining disclosed-stage rows like Series A, B, C, D, Seed, and Pre-Seed.
Are there sector clusters that repeat at meaningful frequency, rather than appearing once?
Several sectors recur, with “Energy” showing up in multiple entries across years (e.g., RIFT on 2026-03-03; LionVolt $16M on 2024-02-12; SparkNano $6M on 2022-11-15; Incooling $4M on 2023-01-16). “Health Care” and “Artificial Intelligence (AI)” also appear repeatedly (e.g., Plasmacure $7M on 2025-07-07; Sirius Medical $10M on 2025-02-04; INNER $60K on 2024-07-10; Autoscriber $1M on 2023-01-11).
Which entries are worth special attention because they combine unusually high (or low) disclosed amounts with distinct sectors or types?
On the high end, Axelera AI’s $250M (2026-02-24) is a major outlier versus other disclosed rounds; on the low end, Belcapo’s $200K (2020-10-07) is the smallest disclosed amount. For type variation, Carbyon’s “Grant” shows up at $1M (2022-04-25) alongside typical equity-style rounds like Xyall’s Series B $6M (2022-05-24), which can be a useful split when triaging deal theses.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.